0001752724-22-024600.txt : 20220210
0001752724-22-024600.hdr.sgml : 20220210
20220210122404
ACCESSION NUMBER: 0001752724-22-024600
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20211130
FILED AS OF DATE: 20220210
DATE AS OF CHANGE: 20220210
EFFECTIVENESS DATE: 20220210
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MASSACHUSETTS INVESTORS GROWTH STOCK FUND
CENTRAL INDEX KEY: 0000063090
IRS NUMBER: 041885327
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1031
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-00859
FILM NUMBER: 22612466
BUSINESS ADDRESS:
STREET 1: 111 HUNTINGTON AVENUE
STREET 2: 21ST FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 18006372929
MAIL ADDRESS:
STREET 1: 111 HUNTINGTON AVENUE
STREET 2: 21ST FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02199
FORMER COMPANY:
FORMER CONFORMED NAME: MASSACHUSETTS INVESTORS GROWTH STOCK FUND INC
DATE OF NAME CHANGE: 19920414
0000063090
S000000695
Massachusetts Investors Growth Stock Fund
C000002023
A
MIGFX
C000002024
R3
MIGHX
C000002025
R4
MIGKX
C000002026
529A
EISTX
C000002027
529B
EMIVX
C000002028
529C
EMICX
C000002029
B
MIGBX
C000002030
C
MIGDX
C000002031
I
MGTIX
C000002034
R1
MIGMX
C000002036
R2
MIRGX
C000112291
R6
MIGNX
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0000063090
XXXXXXXX
811-00859
true
false
false
N-1A
true
MASSACHUSETTS INVESTORS GROWTH STOCK FUND
811-00859
0000063090
IYOONE8CYRIVGIKANH85
111 Huntington Avenue
Boston
02199
US-MA
US
617-954-5000
Iron Mountain Inc.
1 Federal Street
Boston
02110
18008994766
Storage Vendor
JPMorgan Chase
270 Park Avenue
New York
10017
12122706000
Custodian record
Charles River Development
700 District Avenue
Burlington
01803
17812380099
Investment related records
TerraNua U.S. Corp d.b.a. My Compliance Office
535 5th Avenue 4th floor
New York
10017
18669512280
Personal Trading System
Massachusetts Financial Services Company
111 Huntington Avenue
Boston
02199
16179545000
Investment adviser record
MFS Fund Distributors,Inc.
111 Huntington Avenue
Boston
02199
16179545000
Principal underwriter record
Autonomy Corporation Limited
1140 Enterprise Way
Sunnyvale
94089
441223448000
Storage Vendor
Institutional Shareholder Services Inc
702 King Farm Boulevard Suite 400
Rockville
20850
13015560500
Proxy voting administrator
MFS Service Center Inc.
100 Hancock Street
North Quincy
02171
16179545000
Transfer agency record
DST Systems,Inc.
333 West 11thStreet
Kansas City
64105
18164351000
Technology Vendor
The Depository Trust Company
55 Water Street
New York
10041
12128551000
DTC
Ropes&Gray
800 Boylston Street
Boston
02199
16179517000
Counsel record
N
N
N-1A
1
Y
John A. Caroselli
N/A
N
Maureen R. Goldfarb
N/A
N
Laurie J. Thomsen
N/A
N
Maryanne L. Roepke
N/A
N
Clarence Otis, Jr.
N/A
N
James W. Kilman, Jr.
N/A
N
Michael W. Roberge
N/A
Y
Peter D. Jones
N/A
N
Steven E. Buller
N/A
N
John P. Kavanaugh
N/A
N
Martin J. Wolin
004331075
111 Huntington Avenue
Boston
02199
XXXXXX
N
N
N
N
N
N
N
MFS FUND DISTRIBUTORS, INC.
8-45321
000031052
N/A
Y
N
ERNST & YOUNG LLP
42
N/A
N
N
N
N
N
N
Massachusetts Investors Growth Stock Fund
S000000695
IYOONE8CYRIVGIKANH85
N
12
0
0
N/A
N
N
Y
N
N
JPMorgan Chase Bank N.A.
8I5DZWZKVSZI1NUHU748
N
N
Cash collateral reinvestment fee
Revenue sharing split
0.00000000
0.00000000
Rule 17a-7 (17 CFR 270.17a-7)
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 22d-1 (17 CFR 270.22d-1)
Rule 32a-4 (17 CFR 270.32a-4)
Y
Y
N
N
MASSACHUSETTS FINANCIAL SERVICES COMPANY
801-17352
000110045
1G3OSH3GLGJ7X1JC5I61
N
MFS SERVICE CENTER, INC.
84-1316
N/A
Y
N
N
IHS Markit
549300HLPTRASHS0E726
GB
N
ICE Data Pricing & Reference Data, LLC
5493000NQ9LYLDBCTL34
N
Refinitiv U.S. Holdings Inc.
5490300NF240HXJO7N016
N
N
JPMORGAN CHASE BANK
7H6GLXDRUGQFU57RNE97
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
MFS Service Center, Inc.
084-01316
SEC identifier
Y
N
N
MASSACHUSETTS FINANCIAL SERVICES
1G3OSH3GLGJ7X1JC5I61
Y
N
N
UBS Securities LLC
8-22651
000007654
T6FIZBDPKLYJKFCRVK44
18379.31000000
Citigroup Global Markets Inc.
8-08177
000007059
MBNUM2BPBDO7JBLYG310
23552.22000000
Jefferies LLC
8-15074
000002347
58PU97L1C0WSRCWADL48
71060.64000000
BMO Capital Markets Corp.
8-34344
000016686
RUC0QBLBRPRCU4W1NE59
54173.62000000
Credit Suisse Securities (USA) LLC
8-00422
000000816
1V8Y6QCX6YMJ2OELII46
19509.16000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
19180.30000000
Goldman Sachs & Co. LLC
8-00129
000000361
FOR8UP27PHTHYVLBNG30
116598.12000000
National Financial Services LLC
8-26740
000013041
549300JRHF1MHHWUAW04
21401.90000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
40485.34000000
Merrill Lynch, Pierce, Fenner & Smith Inc.
8-07221
000007691
8NAV47T0Y26Q87Y0QP81
50096.88000000
509096.21000000
Healthcare of Ontario Pension Plan Trust Fund
N/A
N/A
KRVONIXV1JBEY6WQ6092
CA
240486.66000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
1344280.14000000
Manufacturers and Traders Trust Company
N/A
N/A
WWB2V0FCW3A0EE3ZJN75
636.48000000
State Street Global Markets, LLC
8-69862
000285852
549300FDEDF5ORXCMQ56
56962102.00999999
Bank of New York Mellon Corp.
N/A
N/A
WFLLPEPC7FZXENRZV188
966898.62000000
MUFG Securities Americas Inc.
8-43026
000019685
K5HU16E3LMSVCCJJJ255
67442.85000000
59581846.75999999
Y
10488389542.84000000
Uncommitted
200000000.00000000
N
Uncommitted
100000000.00000000
N
Committed
1250000000.00000000
N
N
N
N
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
Mass_Audit_Letter.txt
Report of Independent Registered Public Accounting Firm
To the Shareholders and
Board of Trustees of Massachusetts Investors Growth Stock Fund
In planning and performing our audit of the financial statements
of Massachusetts Investors Growth Stock Fund (the "Fund") as of
and for the year ended November 30, 2021, in accordance with the
standards of the Public Company Accounting Oversight Board
(United States), we considered the Fund's internal control over
financial reporting, including controls over safeguarding
securities, as a basis for designing our auditing procedures
for the purpose of expressing our opinion on the financial
statements and to comply with the requirements of Form N-CEN,
but not for the purpose of expressing an opinion on the
effectiveness of the Fund's internal control over financial
reporting. Accordingly, we express no such opinion.
The management of the Fund is responsible for establishing and
maintaining effective internal control over financial reporting.
In fulfilling this responsibility, estimates and judgments by
management are required to assess the expected benefits and
related costs of controls. A company's internal control over
financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes
in accordance with U.S. generally accepted accounting principles.
A company's internal control over financial reporting includes
those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately
and fairly reflect the transactions and dispositions of the
assets of the company; (2) provide reasonable assurance that
transactions are recorded as necessary to permit preparation
of financial statements in accordance with U.S. generally
accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance
with authorizations of management and directors of the company;
and (3) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use or
disposition of a company's assets that could have a material
effect on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists
when the design or operation of a control does not allow
management or employees, in the normal course of performing their
assigned functions, to prevent or detect misstatements on a timely
basis. A material weakness is a deficiency, or a combination of
deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material misstatement
of the company's annual or interim financial statements will not
be prevented or detected on a timely basis.
Our consideration of the Fund's internal control over financial
reporting was for the limited purpose described in the first
paragraph and would not necessarily disclose all deficiencies in
internal control that might be material weaknesses under standards
established by the Public Company Accounting Oversight Board (United
States). However, we noted no deficiencies in the Fund's internal
control over financial reporting and its operation, including
controls over safeguarding securities, that we consider to be a
material weakness as defined above as of November 30, 2021.
This report is intended solely for the information and use of
management and the Board of Trustees of Massachusetts Investors
Growth Stock Fund and the Securities and Exchange Commission and
is not intended to be and should not be used by anyone other than
these specified parties.
/s/ Ernst & Young LLP
Boston, Massachusetts
January 14, 2022